Exosomes as Nanocarrier for Neurotherapy: Journey from Application to Challenges DOI
Yogita Ale, Nidhi Nainwal

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106312 - 106312

Опубликована: Окт. 1, 2024

Язык: Английский

Alginate/magnetic hydroxyapatite bio-nanocomposite hydrogel bead as a pH-responsive oral drug carrier for potential colon cancer therapy DOI Creative Commons
Rauf Foroutan, Ali Mohammadzadeh, Siamak Javanbakht

и другие.

Results in Chemistry, Год журнала: 2025, Номер unknown, С. 102177 - 102177

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

1
The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review DOI
Mohanna Khandan, Mohammad Amin Khazeei Tabari,

Seyed Mostafa Rahimi

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Март 28, 2025

Язык: Английский

Процитировано

0
Exosomes in melanoma: Future potential for clinical theranostics DOI
Asmit Das, Swarup Sonar, Rajib Dhar

и другие.

Pathology - Research and Practice, Год журнала: 2025, Номер unknown, С. 155950 - 155950

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0
Exosome-based cancer vaccine: a cell-free approach DOI
Swarup Sonar, Asmit Das, Ketki Kalele

и другие.

Molecular Biology Reports, Год журнала: 2025, Номер 52(1)

Опубликована: Апрель 24, 2025

Язык: Английский

Процитировано

0
Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application DOI Creative Commons
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan

и другие.

Vaccines, Год журнала: 2024, Номер 12(11), С. 1282 - 1282

Опубликована: Ноя. 15, 2024

Milk-derived extracellular vesicles (mEVs) are emerging as promising therapeutic candidates due to their unique properties and versatile functions. These play a crucial role in immunomodulation by influencing macrophage differentiation cytokine production, potentially aiding the treatment of conditions such bone loss, fibrosis, cancer. mEVs also have capacity modulate gut microbiota composition, which may alleviate symptoms inflammatory bowel diseases promote intestinal barrier integrity. Their potential drug delivery vehicles is significant, enhancing stability, solubility, bioavailability anticancer agents while supporting wound healing reducing inflammation. Additionally, bovine exhibit anti-aging protect skin cells from UV damage. As vaccine platforms, offer advantages including biocompatibility, antigen protection, ability elicit robust immune responses through targeted specific cells. Despite these applications, challenges persist, complex roles cancer, effective loading, regulatory hurdles, need for standardized production methods. Achieving high targeting specificity understanding long-term effects mEV-based therapies essential clinical translation. Ongoing research aims optimize mEV methods, enhance capabilities, conduct rigorous preclinical studies. By addressing challenges, hold revolutionize development delivery, ultimately improving outcomes across various medical fields.

Язык: Английский

Процитировано

1
Exosomes as Nanocarrier for Neurotherapy: Journey from Application to Challenges DOI
Yogita Ale, Nidhi Nainwal

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106312 - 106312

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

0